Aristopharma Ltd

Our Products

Avolac (Lactulose)

Therapeutic Group : Laxative

Share on facebook
Share on twitter
Share on print
Share on email
Lactulose, which is not broken down in the stomach and small intestine, begins its action in the large intestine where it is broken down primarily by intestinal bacteria. In this degradation process, lactic acid is produced; this in turn supports the growth of intestinal bacteria important for human and hinders the growth of putrefactive bacteria. Thus normalization of intestinal flora (eubiosis) results. In addition, the increase in metabolic degradation products in the blood, which cannot be sufficiently detoxified by the liver, is reduced. Lactulose improves the transter of calcium salts and phosphates from the intestines, stimulates intestinal peristalsis and leads to softening of the stool. It also leads to heating and improvement in gum diseases through normalization of metabolic processes in the parodontal region. Even long-term use of Avolac does not lead to habituation and thus there is no loss of efficacy.